The Difference between ME/CFS, CFS, and ME

Dislike of and confusion about the names ME, CFS, and ME/CFS is very common, and few people like the combined term ME/CFS. What matters most is focusing our energy on amplifying awareness, advocating for and supporting research, and improving patients' access to medical care and the ability to manage daily living.

1. ME and CFS are not established as separate diseases in the scientific literature. The combined term ME/CFS is used across research and clinical bodies including the National Academy of Medicine, National Institutes of Health, and Centers for Disease Control and Prevention. Much of the confusion comes from the difference between research criteria, which were designed to include only common or typical presentations, and clinical criteria, which are meant to include as many presentations as possible. This is a difference in selection strategy, not evidence of separate diseases, and the issue is amplified in ME/CFS because the illness is highly heterogeneous.

Definitions like the Fukuda criteria from 1994 were broader and often used in clinical settings or early research, when less was known about ME/CFS. In contrast, the Canadian Consensus Criteria from 2003, which explicitly uses the term ME/CFS, and the International Consensus Criteria from 2011 were developed largely as research criteria to select more uniform or typical patient groups. These criteria are applying different inclusion thresholds to study the same illness, not identifying different diseases.

As research has progressed, it has become clear that ME/CFS is highly heterogeneous, and overly narrow research cohorts can exclude many genuine patients. The 2015 IOM criteria focus on core features like post-exertional malaise while still reflecting the range of presentations seen in this illness.

There is no evidence that ME and CFS are separate diseases with different mechanisms. Different criteria sets exist, some designed for research selection and some for clinical diagnosis, but all describe the same underlying condition.

2. The idea that CFS is just fatigue is inaccurate. Even the older Fukuda criteria require a constellation of symptoms, and modern criteria focus on post-exertional malaise, cognitive dysfunction, sleep disturbance, and autonomic or immune features. This is why our group asks people if they meet the criteria, not whether they have been formally diagnosed.

3. There is no evidence for a separate biopsychosocial version of ME/CFS. After decades of research, no study has identified a subgroup of patients with a purely psychological or emotion-driven form of this illness. What has been repeatedly documented across patient cohorts are immune abnormalities, such as cytokine patterns; metabolic dysfunction, such as a hypometabolic state; neuroinflammation and neurological changes; and reproducible physiological abnormalities on exertion.

These findings are present across patients labeled ME, CFS, or ME/CFS. There is no validated biological distinction that splits them into different diseases.

4.  While some criteria, like the ICC, use the term PENE, post-exertional malaise is the more widely used term in research. Both describe the same core phenomenon: a pathological worsening after exertion, not ordinary fatigue.

5.  Severity differences do not define different diseases. ME/CFS is a dynamic illness, and people can move between mild, moderate, severe, and very severe. Creating a divide where ME equals severe and CFS equals mild is not supported by evidence and risks minimizing patients at all levels of severity. Even those with the mildest presentations experience symptoms, have lost significant functioning, and must manage their exertion carefully.